Study Indicates The Potential Value Of Optos’ Widefield Retinal Imaging Technology In The Detection Of Alzheimer’s Disease

LONDON, UK, 04 May 2011 - Optos plc (LSE: OPTS), a leading medical retinal imaging company, announced the results of twenty positive clinical studies at The Association for Research in Vision and Ophthalmology (ARVO) Annual Meeting in Fort Lauderdale May 1-4, 2011, including a study investigating the use of its retinal imaging technology to diagnose Alzheimer's Dementia in the eye.